Rafet Başar

Delivery technologies for cancer immunotherapy

Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence

Plasmapheresis for Preventing Complication of Hypertriglyceridemia

Opportunities for Treg cell therapy for the treatment of human disease

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Tregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins inALS

Expanded autologous regulatory T-lymphocyte infusions in ALS

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Clinical features and treatment of hypertriglyceridemia‐induced acute pancreatitis during pregnancy: A retrospective study

Therapeutic apheresis for severe hypertriglyceridemia in pregnancy

A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML